pillbase.ru

Tecentriq

Active substance: atezolizumab

atezolizumab

Centralised EU authorisationActive

Marketing holder: Roche Registration GmbH

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 3
  • Тецентрик®
    концентрат для приготовления раствора для инфузий, 60 мг/мл, 20 мл (original in Russian, GRLS)
    ЛП-№(001980)-(РГ-RU)
    Ф.Хоффманн-Ля Рош Лтд
  • Тецентрик®
    раствор для подкожного введения, 1875 мг, 15 мл (original in Russian, GRLS)
    ЛП-№(010982)-(РГ-RU)
    Ф.Хоффманн-Ля Рош Лтд
  • Тецентрик®
    концентрат для приготовления раствора для инфузий, 60 мг/мл, 20 мл (original in Russian, GRLS)
    ЛП-004652
    Ф. Хоффманн-Ля Рош Лтд.
US 3
  • TECENTRIQ
    INJECTION, SOLUTION · ATEZOLIZUMAB 1200 mg/20mL
    50242-917
    Genentech, Inc.
  • TECENTRIQ
    INJECTION, SOLUTION · ATEZOLIZUMAB 840 mg/14mL
    50242-918
    Genentech, Inc.
  • Tecentriq Hybreza
    INJECTION · ATEZOLIZUMAB 1875 mg/15mL, HYALURONIDASE (HUMAN RECOMBINANT) 30000 U/15mL
    50242-933
    Genentech, Inc.
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-4439-7546-8a94-f3005e0c57fe,01a120c3-bbd6-71a4-9c06-64452c72e7d2,01a120c5-c3ab-792d-a507-bdf6e6502762;count=3 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a12096-00fb-73a8-a7d9-4c4d13163235,01a1209b-0e87-7034-a81e-31d595137842;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004143
Registration status
Active
ATC code
L01XC32
Sources
  • product · EMA · EMEA/H/C/004143 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004143 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004143 · Verified 2026-10-09